BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35413782)

  • 1. A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus.
    Lee S; Jeon S; Kim HS
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):195-207. PubMed ID: 35413782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Recent Developments and Progress in Computational Drug Repositioning.
    Shi W; Chen X; Deng L
    Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
    Yang CC; Zhao M
    Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
    Katare PB; Banerjee SK
    Curr Top Med Chem; 2016; 16(19):2189-200. PubMed ID: 26881721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
    Mayers M; Li TS; Queralt-Rosinach N; Su AI
    BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents.
    Zhu S; Bai Q; Li L; Xu T
    Comput Struct Biotechnol J; 2022; 20():2839-2847. PubMed ID: 35765655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
    Su EW
    Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of the methodology in drug repurposing using human genomic data: a systematic review.
    Wang L; Lu Y; Li D; Zhou Y; Yu L; Mesa Eguiagaray I; Campbell H; Li X; Theodoratou E
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38279645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-Based Approaches for Drug Repositioning.
    Song T; Wang G; Ding M; Rodriguez-Paton A; Wang X; Wang S
    Mol Inform; 2022 May; 41(5):e2100200. PubMed ID: 34970871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.